Canaccord Genuity Maintains Buy on Health Catalyst, Raises Price Target to $3
Wells Fargo Maintains Equal-Weight on Health Catalyst, Raises Price Target to $1.75
Health Catalyst to Participate in Upcoming Investor Conference
Med-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue Yield
Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation
Health Catalyst Agrees To Divest Vitalware And Vitalware Business Unit To Med-Metrix For Total Consideration Of $147M In Cash
5 Insightful Analyst Questions From Health Catalyst’s Q1 Earnings Call
Health Catalyst (HCAT) Stock Trades Up, Here Is Why
Health Catalyst (HCAT) Reports Q1: Everything You Need To Know Ahead Of Earnings
Stephens & Co. Maintains Equal-Weight on Health Catalyst, Lowers Price Target to $1.75
Health Catalyst Inc (HCAT) Q1 2026 Earnings Call Highlights: Surpassing Expectations with ...
Health Catalyst, Inc. (HCAT) Q1 2026 Earnings Call Transcript
Health Catalyst Q1 Earnings Call Highlights
Health Catalyst (HCAT) Q1 2026 Earnings Transcript
Compared to Estimates, Health Catalyst (HCAT) Q1 Earnings: A Look at Key Metrics
Health Catalyst (NASDAQ:HCAT) Q1 2026 Revenue Beat, Strategic Reset Fuel 11% Stock Surge
Health Catalyst’s (NASDAQ:HCAT) Q1 CY2026 Sales Beat Estimates, Stock Jumps 11.1%
Health Catalyst Reports First Quarter 2026 Results
Health Catalyst Sees Q2 Sales $68.000M-$70.000M vs $70.752M Est
Health Catalyst Q1 Adj. EPS $0.02, Inline, Sales $70.756M Beat $69.171M Estimate
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.